Although this study cannot definitively establish a direct link between the two serum biomarkers (sNfL and GFAP) and the optic nerve damage, it provides valuable evidence suggesting ongoing neuroaxonal degeneration even in the chronic stages of both LHON and ADOA. The gene discussed is GFAP; the disease is autosomal dominant optic atrophy.